SCA Pharma, a recognized leader in the field of sterile compounding, will attend the HCP20 Hospital Pharmacy Virtual Spring Conference June 2-4 and June 9-11, 2020. The conference will be held virtually this spring due to the COVID-19 pandemic.
The HCP conference offers participants a chance to connect with the nation’s leading suppliers, attend continuing education sessions and learn about the industry’s latest clinical, technological and regulatory information.
SCA Pharma is an FDA 503B outsourcing facility providing the highest quality sterile admixtures and pre-filled syringes. Licensed in all 50 states, SCA Pharma specializes in preparing sterile pharmaceuticals customized for hospital pharmacies and healthcare facilities nationwide.
Headquartered in Little Rock, Arkansas, SCA Pharma has two state-of-the-art production facilities in both Arkansas and Connecticut. To connect with SCA Pharma, contact email@example.com
This post is related to:Admixture Compounding Services (503B Outsourcing Facilities)